More about

Fred Hutchinson

News
August 06, 2020
2 min read
Save

NCCN patient guidelines provide ‘basic understanding’ of CAR T-cell therapy toxicities

NCCN patient guidelines provide ‘basic understanding’ of CAR T-cell therapy toxicities

The National Comprehensive Cancer Network published the latest in its series of guidelines intended to inform patients and their caregivers about adverse events associated with cancer therapies.

News
July 29, 2020
2 min read
Save

Q&A: Millions of volunteers needed for COVID-19 vaccine trials

Q&A: Millions of volunteers needed for COVID-19 vaccine trials

The NIH recently announced the launch of a collaborative effort to test vaccine candidates for COVID-19 in the United States.

News
July 20, 2020
5 min read
Save

Exploring alternatives to CAR T-cell therapy

Exploring alternatives to CAR T-cell therapy

In this installment of In Practice, Ryan D. Cassaday, MD, explains how to negotiate the delicate balancing act required when discussing alternatives to chimeric antigen receptor T-cell therapy with patients and referring colleagues.

News
July 14, 2020
3 min read
Save

FDA panel supports approval of belantamab mafodotin for relapsed/refractory myeloma

FDA panel supports approval of belantamab mafodotin for relapsed/refractory myeloma

An FDA advisory committee today voted unanimously to recommend approval of belantamab mafodotin for patients with relapsed or refractory multiple myeloma, concluding the clinical benefits outweigh potential risks that include keratopathy.

News
July 11, 2020
1 min read
Save

Nine investigators to share $6.75 million for blood cancer research

Three organizations awarded grants totaling $6.75 million to fund research into blood cancers.

News
July 06, 2020
2 min read
Save

NIH awards grant to UCLA to develop CAR T-cell therapies for HIV

NIH awards grant to UCLA to develop CAR T-cell therapies for HIV

The NIH awarded a $13.65 million grant to researchers at University of California, Los Angeles, to develop chimeric antigen receptor T-cell therapies for the treatment of HIV.

News
June 25, 2020
2 min read
Save

Black patients less represented in pharmaceutical-led vs. NCI-sponsored cancer trials

Black patients less represented in pharmaceutical-led vs. NCI-sponsored cancer trials

Black patients with cancer have been significantly underrepresented in pharmaceutical company-sponsored clinical trials, according to study results presented at American Association for Cancer Research Virtual Annual Meeting II.

News
June 24, 2020
2 min read
Save

Readmission rates reaffirm post-CAR-T infusion care policies

Readmission rates reaffirm post-CAR-T infusion care policies

A 14% readmission rate after receipt of axicabtagene ciloleucel supports policies that require monitoring by a caregiver after discharge, according to results of a single-center study presented during the ASCO20 Virtual Scientific Program.

News
June 12, 2020
2 min read
Save

Insurance status linked to survival benefit in cancer treatment trials

Insurance status linked to survival benefit in cancer treatment trials

Patients with cancer who either had Medicaid or no health insurance derived smaller benefits from experimental therapies than standard therapies in clinical trials, according to results of a meta-analysis published in JAMA Network Open.

News
June 01, 2020
4 min read
Save

Adjuvant atezolizumab fails to extend DFS in high-risk urothelial carcinoma

Adjuvant atezolizumab fails to extend DFS in high-risk urothelial carcinoma

Adjuvant atezolizumab failed to extend DFS compared with observation for patients with high-risk muscle-invasive urothelial carcinoma, according to randomized phase 3 study results presented during the ASCO20 Virtual Scientific Program.

View more